Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|May 5, 2016
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitationThang Ho, Bruce G Pollock, Benoit H Mulsant, et al.
American Journal of Alzheimer'S Disease and Other Dementias|July 5, 2018
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's DiseaseYe Tao, Matthew E Peters, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 10, 2013
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2Crystal V Flynn Longmire, Lea T Drye, Constantine E Frangakis, et al.
International Journal of Geriatric Psychiatry|June 10, 2024
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)Lijuan Zeng, Jamie Perin, Alden L Gross, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 23, 2020
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of InstrumentsKrista L Lanctôt, Roberta W Scherer, Abby Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 4, 2012
Citalopram for agitation in Alzheimer's disease: design and methodsLea T Drye, Zahinoor Ismail, Anton P Porsteinsson, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 18, 2021
Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration StudiesAdam P Spira, Vadim Zipunnikov, Rema Raman, et al.
JAMA|February 20, 2014
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trialAnton P Porsteinsson, Lea T Drye, Bruce G Pollock, et al.
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
Pageof 5